Cargando…

A Review of the Potential Application of Osteocyte-Related Biomarkers, Fibroblast Growth Factor-23, Sclerostin, and Dickkopf-1 in Predicting Osteoporosis and Fractures

Bone turnover markers (BTMs) derived from the secretory activities of osteoblasts and the matrix-degrading activities of osteoclasts are useful in monitoring the progression of osteoporosis and the efficacy of anti-osteoporotic treatment. However, the usefulness of BTMs in predicting osteoporosis re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramli, Fitri Fareez, Chin, Kok-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151094/ https://www.ncbi.nlm.nih.gov/pubmed/32155909 http://dx.doi.org/10.3390/diagnostics10030145

Ejemplares similares

Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
por: Ueland, Thor, et al.
Publicado: (2019)

Pharmacogenomics biomarkers for personalized methadone maintenance treatment: The mechanism and its potential use
por: Ramli, Fitri Fareez
Publicado: (2021)

Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
por: Gerov, Vladimir, et al.
Publicado: (2023)

The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
por: Siegenthaler, Barbara, et al.
Publicado: (2018)

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023)

Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
por: Laster, Marciana, et al.
Publicado: (2023)

Clinical management of chronic mercury intoxication secondary to skin lightening products: A proposed algorithm
por: Ramli, Fitri Fareez
Publicado: (2021)

Suppression of Sost/Sclerostin and Dickkopf‐1 Augment Intervertebral Disc Structure in Mice
por: Kroon, Tori, et al.
Publicado: (2022)

IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
por: Jiang, Zengxin, et al.
Publicado: (2023)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
por: Peng, Jia, et al.
Publicado: (2021)

Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
por: Liu, Wen, et al.
Publicado: (2019)

Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes
por: Pacicca, Donna M., et al.
Publicado: (2019)

Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes
por: Qin, Lei, et al.
Publicado: (2021)

Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin
por: Knowles, Helen J., et al.
Publicado: (2023)

Osteoclast and Sclerostin Expression in Osteocytes in the Femoral Head with Risedronate Therapy in Patients with Hip Fractures: A Retrospective Comparative Study
por: Lee, Hwan-Hee, et al.
Publicado: (2022)

Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
por: Wijenayaka, Asiri R., et al.
Publicado: (2011)

Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
por: Stegen, Steve, et al.
Publicado: (2018)

Effect of TNF-α-Induced Sclerostin on Osteocytes during Orthodontic Tooth Movement
por: Ohori, Fumitoshi, et al.
Publicado: (2019)

Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
por: Choi, Hong Y., et al.
Publicado: (2009)

The role of sclerostin and dickkopf-1 in oral tissues – A review from the perspective of the dental disciplines
por: Samiei, Mohammad, et al.
Publicado: (2019)

Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study
por: Klingenschmid, Gerhard, et al.
Publicado: (2020)

Sclerostin as a biomarker of physical exercise in osteoporosis: A narrative review
por: Oniszczuk, Anna, et al.
Publicado: (2022)

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
por: van Bezooijen, Rutger L., et al.
Publicado: (2004)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
por: Toscani, Denise, et al.
Publicado: (2018)

Osteocyte expression of caspase-3, COX-2, IL-6 and sclerostin are spatially and temporally associated following stress fracture initiation
por: Wu, Andy C, et al.
Publicado: (2014)

The Health Argument of Climate Action during COP26: Commentaries on Mental Health Issues
por: Ramli, Fitri Fareez, et al.
Publicado: (2023)

Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes
por: Kratochvilova, Adela, et al.
Publicado: (2021)

Changes in expression of Wnt signaling pathway inhibitors dickkopf-1 and sclerostin before and after total joint arthroplasty
por: Lu, Ke, et al.
Publicado: (2017)

Sclerostin, an emerging therapeutic target for treating osteoporosis and osteoporotic fracture: A general review
por: Suen, Pui Kit, et al.
Publicado: (2015)

Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels
por: Kawai, Masanobu, et al.
Publicado: (2020)

Molecular-Signaling Pathways of Ginsenosides Rb in Myocardial Ischemia-Reperfusion Injury: A Mini Review
por: Ramli, Fitri Fareez, et al.
Publicado: (2022)

Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems Model
por: Eudy, RJ, et al.
Publicado: (2015)

Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
por: Basha, Genc, et al.
Publicado: (2016)

Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis
por: Kim, Ji-Hye, et al.
Publicado: (2017)

The Influence of Pro-Inflammatory Factors on Sclerostin and Dickkopf-1 Production in Human Dental Pulp Cells Under Hypoxic Conditions
por: Janjić, Klara, et al.
Publicado: (2019)

Relation of Wnt Signaling Pathway Inhibitors (Sclerostin and Dickkopf-1) to Left Ventricular Mass Index in Maintenance Hemodialysis Patients
por: Bahie, Ahmed, et al.
Publicado: (2021)

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis
por: Wang, Alice, et al.
Publicado: (2021)

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
por: Fabre, Stéphanie, et al.
Publicado: (2020)

The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis
por: Martiniakova, Monika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hbhqvr9ntv0mlvdk2iq8ukn40u